Ownership

Neil Stahl - EVP Research and Development at Regeneron Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: EVP Research and Development
Stock Symbol: REGN on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Neil Stahl - trading volume in the past year for Regeneron Pharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-5.2K	100%	$1,084.54	-$5.64M
Net	-5.2K	-100%		-$5.64M

Holdings reported by Neil Stahl for Regeneron Pharmaceuticals, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	48.8K	$35.7M	$730.81	Dec 16, 2024	Direct
Common Stock	5.85K	$4.27M	$730.81	Dec 16, 2024	By 401(k) Plan
Common Stock	4.61K	$3.37M	$730.81	Dec 16, 2024	by Spouse as Trustee
Non-Qualified Stock Option (right to buy)	45K			Aug 2, 2024	Direct	Common Stock
Non-Qualified Stock Option (right to buy)	0			Feb 2, 2024	Direct	Common Stock

Transactions reported by Neil Stahl for Regeneron Pharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.